Paliperidone
Links shared publicly online about this topic
INVEGA (Paliperidone) drug information from MPR
empr.com — “INVEGA (Paliperidone) drug information for Schizoaffective disorder, Schizophrenia from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.” View full resource at empr.com
Most Recently Shared on June 9, 2011 at 4:45 am By:
MPR News: INVEGA: Indications: added schizophrenia in adolescents. http://bit.ly/AMzNg
Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder
jnj.com — “Johnson & Johnson news and information regarding our operations, products, leaders, and our charitable giving.” View full resource at jnj.com
Most Recently Shared on April 1, 2009 at 9:39 pm By:
eyeonfda Pharma and Health Lawyer
JNJ Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder http://is.gd/qaBC
INVEGA® (Paliperidone ER) Approved As First Antipsychotic Treatment For Schizoaffective Disorder In The EU
medicalnewstoday.com — “Janssen-Cilag International NV has received approval from the European Commission for the first antipsychotic treatment for schizoaffective disorder. INVEGA® (paliperidone ER) is now indicate” View full resource at medicalnewstoday.com
Most Recently Shared on January 7, 2011 at 2:05 pm By:
MNT Depression News Health News
INVEGA® (Paliperidone ER) Approved As First Antipsychotic Treatment For Schizoaffective Disorder In The EU http://mnt.to/3PJm
Paliperidone palmitate: Once-monthly treatment option for schizophrenia — Current Psychiatry Online
currentpsychiatry.com — “Paliperidone palmitate: Once-monthly treatment option for schizophrenia — Current Psychiatry Online” View full resource at currentpsychiatry.com
Most Recently Shared on March 17, 2010 at 11:54 am By:
Current Psychiatry Psychiatry and Medical Journal
Paliperidone palmitate: Once-monthly treatment option for #schizophrenia http://bit.ly/bWxNMC
Neurology Article | Dosing and switching strategies for paliperidone palmitate: Based on population pharmacokinetic modelling and clinical trial data
mdlinx.com — “Dosing and switching strategies for paliperidone palmitate: Based on population pharmacokinetic modelling and clinical trial data” View full resource at mdlinx.com
Most Recently Shared on September 30, 2011 at 2:33 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Dosing and switching strategies for paliperidone palmitate: Based on population pharmacokinetic modelling... http://t.co/pfMFmpwm #neuro
Onset of Efficacy and Tolerability Following the Initiation Dosing of Long-Acting Paliperidone Palmitate - QualityPoint Technologies
qualitypointtech.net — “This analysis addresses two common questions regarding long-acting paliperidone palmitate injection for schizophrenia: how quickly is efficacy reached, and how well tolerated is the first dose? BMC Psychiatry” View full resource at qualitypointtech.net
Most Recently Shared on August 9, 2011 at 11:45 am By:
Onset of Efficacy and Tolerability Following the Initiation Dosing of Long-Acting Paliperidone Palmitate: This ana... http://bit.ly/oN4Wal
Janssen-Cilag Submits Marketing Authorisation Application in Europe for Paliperidone Palmitate for the Treatment of Schizophrenia
jnj.com — “Johnson & Johnson news and information regarding our operations, products, leaders, and our charitable giving.” View full resource at jnj.com
Most Recently Shared on December 7, 2009 at 5:24 pm By:
eyeonfda Pharma and Health Lawyer
Janssen-Cilag Submits EU Application for Paliperidone Palmitate for Trtmnt of Schizophrenia - http://ow.ly/Jzua
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings For Paliperidone Palmitate And Invega
jnj.com — “Johnson & Johnson news and information regarding our operations, products, leaders, and our charitable giving.” View full resource at jnj.com
Most Recently Shared on February 6, 2009 at 3:51 pm By:
eyeonfda Pharma and Health Lawyer
J & J Announces FDA Filings For Paliperidone Palmitate And Invega® for patients with schizophrenia - http://is.gd/iDaz
Randomized, Double-Blind, Placebo-Controlled Study of Paliperidone Extended-Release and Quetiapine in Inpatients With Recently Exacerbated Schizophrenia -- Canuso et al., 10.1176/appi.ajp.2009.08040613 -- Am J Psychiatry
ajp.psychiatryonline.org — “Randomized, Double-Blind, Placebo-Controlled Study of Paliperidone Extended-Release and Quetiapine in Inpatients With Recently Exacerbated Schizophrenia -- Canuso et al., 10.1176/appi.ajp.2009.08040613 -- Am J Psychiatry” View full resource at ajp.psychiatryonline.org
Most Recently Shared on May 1, 2009 at 4:50 pm By:
psychiatryrounds Psychiatry and Support
AJP Psychiatry Journ [research-article] Randomized, Double-Blind, Placebo-Controlled Study o.. http://tinyurl.com/dd2vvd
FDA Approves Invega Sustenna for the Acute and Maintenance Treatment of Schizophrenia
drugs.com — “Invega Sustenna (paliperidone palmitate) is used to treat schizophrenia. Includes Invega Sustenna side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 3, 2009 at 11:57 pm By:
FDA Approves Invega Sustenna for the Acute and Maintenance Treatment of Schizophrenia - http://bit.ly/JkPxL
Psychiatry Medical News about Pharmacokinetics
mdlinx.com — “The Pharmacokinetics of Paliperidone Versus Risperidone” View full resource at mdlinx.com
Most Recently Shared on February 16, 2010 at 5:27 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Psychiatry: The Pharmacokinetics of Paliperidone Versus Risperidone: Psychosomatics http://url4.eu/1PogM
Psychiatry Medical News about Clozapine
mdlinx.com — “Clozapine Combined with Paliperidone” View full resource at mdlinx.com
Most Recently Shared on March 19, 2010 at 8:24 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Clozapine Combined with Paliperidone: German Journal of Psychiatry http://bit.ly/aOVJa6 #PSY
Psychiatry Medical News about Pharmacokinetics
mdlinx.com — “The Pharmacokinetics of Paliperidone Versus Risperidone” View full resource at mdlinx.com
Most Recently Shared on February 16, 2010 at 5:35 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Psych: The Pharmacokinetics of Paliperidone Versus Risperidone: Psychosomatics http://bit.ly/bUKiYV
Psychiatry Medical News about Palmitates
mdlinx.com — “Intramuscular Paliperidone Palmitate” View full resource at mdlinx.com
Most Recently Shared on February 26, 2010 at 5:23 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Psych: Intramuscular Paliperidone Palmitate: CNS Drugs http://bit.ly/a2krcv
INVEGA(R) Approved As First And Only Antipsychotic Treatment For Schizoaffective Disorder In The European Union
medicalnewstoday.com — “Janssen-Cilag International NV announced that it has received approval from the European Commission for the first antipsychotic treatment for schizoaffective disorder. INVEGA® (paliperidone ER” View full resource at medicalnewstoday.com
Most Recently Shared on January 5, 2011 at 3:05 pm By:
INVEGA(R) Approved As First And Only Antipsychotic Treatment For Schizoaffective Disorder In The European Union http://mnt.to/3PCS
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
-
MNT Depression News
The latest depression news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
